Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

THE CAUSES AND MANAGEMENT OF HIP INSTABILITY: AN ALGORITHMIC APPROACH

Current Concepts in Joint Replacement (CCJR) – Winter 2014



Abstract

Introduction:

Recurrent dislocation following total hip arthroplasty (THA) is a complex, multifactorial problem that has been shown to be the most common indication for revision THA. The purpose of this study was to classify causes of instability and evaluate outcomes based on an algorithmic approach to treatment.

Methods:

Two surgeons performed 77 consecutive revisions for instability. Patients had a mean of 2 years (range, 0 to 6) prior operative attempts to resolve their instability. Subjects were divided into 6 types based on the etiology of instability: I) malposition of the acetabular component, II) malposition of the femoral component, III) abductor deficiency, IV) impingement, V) late wear, or VI) unclear etiology. Types I /II were treated with revision of the malpositioned component, Type III/VI with a constrained liner, Type IV by removing sources of impingement and Type V with a liner change. Large (>36mm) femoral heads were used routinely.

Results:

The causes of instability were Type I: 25 (33%); Type II: 8 (10%); Type III: 28 (37%); Type IV: 7 (9%); Type V: 5 (7%); Type VI: 3 (4%). At a mean of 32.5 months (Range, 24 to 79) 12 patients re-dislocated (15.6%). Among these 12 failures 8 (75%) were in patients with abductor insufficiency (Type III) treated with a constrained liner.

Conclusions:

The most common causes of instability were cup malposition and abductor insufficiency. Our treatment protocol had an 84.4% success rate. The highest risk of failure was in patients with abductor insufficiency with a revision for other etiologies having a success rate of 92%.